Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Public Notice of Revocation of Certification, 20354 [07-1994]

Download as PDF jlentini on PROD1PC65 with NOTICES 20354 Federal Register / Vol. 72, No. 78 / Tuesday April 24, 2007 / Notices Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Neurotoxicology and Alcohol Study Section. Date: June 14–15, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Churchill Hotel, 1914 Connecticut Avenue, NW., Washington, DC 20009. Contact Person: Joseph G. Rudolph, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD 20892, 301–435– 2212, josephru@csr.nih.gov. Name of Committee: Health of the Population Integrated Review Group; Epidemiology of Cancer Study Section. Date: June 14–15, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Admiral Fell Inn, 888 South Broadway, Baltimore, MD 21231. Contact Person: Denise Wiesch, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, (301) 435– 0684, wieschd@csr.nih.gov. Name of Committee: Immunology Integrated Review Group; Immunity and Host Defense Study Section. Date: June 14–15, 2007. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC 20005. Contact Person: Patrick K. Lai, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 20892, 301–435– 1052, laip@csr.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Neurogenesis and Cell Fate Study Section. Date: June 14–15, 2007. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, DC 20037. Contact Person: Lawrence Baizer, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4152, MSC 7850, Bethesda, MD 20892, (301) 435– 1257, baizerl@csr.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Synthetic and Biological Chemistry B Study Section. Date: June 14–15, 2007. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: DoubleTree Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Mike Radtke, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of VerDate Aug<31>2005 18:32 Apr 23, 2007 Jkt 211001 Health, 6701 Rockledge Drive, Room 4176, MSC 7806, Bethesda, MD 20892, 301–435– 1728, radtkem@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 17, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–2035 Filed 4–23–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Public Notice of Revocation of Certification Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: The Substance Abuse and Mental Health Services Administration has revoked the certification to provide opioid assisted treatment for the three opioid treatment programs listed below. DATES: The revocation of certification was effective on March 20, 2007. FOR FURTHER INFORMATION CONTACT: Nicholas Reuter, Center for Substance Abuse Treatment (CSAT), Division of Pharmacologic Therapies, SAMHSA, One Choke Cherry Road, Rm 2–1063, Rockville, MD 20857, (240) 276–2716, email: Nicholas.Reuter@samhsa.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In a notice published in the Federal Register of January 17, 2001 (66 FR 4076, January 17, 2001), the Substance Abuse and Mental health Services Administration (SAMHSA) issued final regulations for the use of narcotic drugs in maintenance and detoxification treatment of opioid addiction. That final rule established an accreditation-based regulatory system under 42 CFR part 8 (‘‘Certification of Opioid Treatment Programs,’’ ‘‘OTPs’’). The SAMHSA regulations establish the standards for determining that practitioners (programs) are qualified for Drug Enforcement Administration (DEA) registration under 21 U.S.C. 821(g)(1). Qualified programs are granted certification. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 The regulations establish the conditions for certification as well as the criteria for the suspension or revocation of SAMHSA certification. In addition, Subpart C sets forth the procedures for review of suspension or proposed revocation of OTP certification. The Administrator of SAMHSA proposed to decertify these three programs in August 2006. As set forth under 42 CFR part 8, subpart C, each OTP requested a review of the Administrator’s proposal, and submitted documents and briefs to a designated reviewing official for consideration, that were incorporated into an administrative review record. After considering the available information and evidence, the reviewing officials, in upholding the Administrator’s proposal to revoke certification, found that the OTPs listed below were in violation of Federal Opioid Treatment Program Regulations (42 CFR § 8.11,8.14). 1. New Horizon Rehabilitation Services, 4809 W. Chicago Ave., Chicago, IL 60651. 2. Turning Point Treatment Center, Inc., 210 Commerce St., Blairsville, Georgia 30512. 3. Bay Area C.A.R.E. Center, Inc., 3138 South Alameda, Corpus Christi, Texas 78404. Dated: April 13, 2007. Terry L. Cline, Administrator, Substance Abuse and Mental Health Services Administration. [FR Doc. 07–1994 Filed 4–23–07; 8:45 am] BILLING CODE 4160–20–M DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5117–N–34] Notice of Submission of Proposed Information Collection to OMB; Servicemembers Civil Relief Office of the Chief Information Officer, HUD. ACTION: Notice. AGENCY: SUMMARY: The proposed information collection requirement described below has been submitted to the Office of Management and Budget (OMB) for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments on the subject proposal. Federal law requires lenders to send a statement or notice to homeowners in default explaining the mortgage and foreclosure rights of servicemembers and their dependents under the Servicemembers Civil Relief Act (50 E:\FR\FM\24APN1.SGM 24APN1

Agencies

[Federal Register Volume 72, Number 78 (Tuesday, April 24, 2007)]
[Notices]
[Page 20354]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Opioid Drugs in Maintenance and Detoxification Treatment of 
Opiate Addiction; Public Notice of Revocation of Certification

AGENCY: Substance Abuse and Mental Health Services Administration 
(SAMHSA), Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Substance Abuse and Mental Health Services Administration 
has revoked the certification to provide opioid assisted treatment for 
the three opioid treatment programs listed below.

DATES: The revocation of certification was effective on March 20, 2007.

FOR FURTHER INFORMATION CONTACT: Nicholas Reuter, Center for Substance 
Abuse Treatment (CSAT), Division of Pharmacologic Therapies, SAMHSA, 
One Choke Cherry Road, Rm 2-1063, Rockville, MD 20857, (240) 276-2716, 
e-mail: Nicholas.Reuter@samhsa.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In a notice published in the Federal Register of January 17, 2001 
(66 FR 4076, January 17, 2001), the Substance Abuse and Mental health 
Services Administration (SAMHSA) issued final regulations for the use 
of narcotic drugs in maintenance and detoxification treatment of opioid 
addiction. That final rule established an accreditation-based 
regulatory system under 42 CFR part 8 (``Certification of Opioid 
Treatment Programs,'' ``OTPs''). The SAMHSA regulations establish the 
standards for determining that practitioners (programs) are qualified 
for Drug Enforcement Administration (DEA) registration under 21 U.S.C. 
821(g)(1). Qualified programs are granted certification.
    The regulations establish the conditions for certification as well 
as the criteria for the suspension or revocation of SAMHSA 
certification. In addition, Subpart C sets forth the procedures for 
review of suspension or proposed revocation of OTP certification.
    The Administrator of SAMHSA proposed to decertify these three 
programs in August 2006. As set forth under 42 CFR part 8, subpart C, 
each OTP requested a review of the Administrator's proposal, and 
submitted documents and briefs to a designated reviewing official for 
consideration, that were incorporated into an administrative review 
record. After considering the available information and evidence, the 
reviewing officials, in upholding the Administrator's proposal to 
revoke certification, found that the OTPs listed below were in 
violation of Federal Opioid Treatment Program Regulations (42 CFR Sec.  
8.11,8.14).
    1. New Horizon Rehabilitation Services, 4809 W. Chicago Ave., 
Chicago, IL 60651.
    2. Turning Point Treatment Center, Inc., 210 Commerce St., 
Blairsville, Georgia 30512.
    3. Bay Area C.A.R.E. Center, Inc., 3138 South Alameda, Corpus 
Christi, Texas 78404.

    Dated: April 13, 2007.
Terry L. Cline,
Administrator, Substance Abuse and Mental Health Services 
Administration.
[FR Doc. 07-1994 Filed 4-23-07; 8:45 am]
BILLING CODE 4160-20-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.